Studieoverzicht

 
 
  2015-03 POSITIVE       Open       Adjuvant       Any HER2, HR+       Premenopausal  
  2006-05 IDEAL       Follow up       Adjuvant       Any HER2, HR+       Postmenopausal  
  2006-04b TEAM IIb       Closed       Adjuvant       Any HER2, HR+       Postmenopausal  
  2006-04a TEAM IIa       Closed       Neoadjuvant       Any HER2, HR+       Postmenopausal  
  2006-01 DATA       Follow up       Adjuvant       Any HER2, HR+       Postmenopausal  
  2001-01 TEAM       Closed       Adjuvant       Any HER2, HR+       Postmenopausal